Crohn’s disease

Survey: 40% of Americans’ Daily Lives are Disrupted by Digestive Troubles

The American Gastroenterological Association (AGA) recently launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a health care provider. As part of the campaign, AGA released new data that shows nearly 40% of Americans have stopped routine activities in the last year due to uncomfortable bowel symptoms, including ...

Read More »

Business Partnership May Increase Delivery of Gut-Directed Hypnotherapy for IBS Patients

GI OnDEMAND, a virtual integrated care platform, recently announced a partnership with Mindset Health, the creator of Nerva, a six-week gut-directed hypnotherapy program. The hypnotherapy program is delivered through a mobile app to help patients with irritable bowel syndrome (IBS) better manage their symptoms. GI OnDEMAND is a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., ...

Read More »

Crohn’s & Colitis Foundation selected for FDA MyStudies app project

The Crohn’s & Colitis Foundation was selected as one of two patient organizations to participate in an U.S. Food & Drug Administration (FDA) Real-World Evidence Program demonstration project using the FDA MyStudies App through the FDA-Catalyst system. The FDA Real World Evidence Program will inform the assessment of the fitness for use of real-world data to support real-world evidence generation for ...

Read More »

Crohn’s disease study identifies genetic variant with potential to personalize treatment

The largest study ever to look at why an expensive and commonly–used group of drugs fails some patients with Crohn’s disease has identified a genetic marker which could individualize drug treatment. A UK wide collaboration led by the University of Exeter, Royal Devon & Exeter NHS Foundation Trust and the Wellcome Sanger Institute, has demonstrated that a genetic variant carried by 40% of the ...

Read More »